BATs, Balancing

BAT's Balancing Act: Smokeless Growth vs. Structural Headwinds in the Half-Year Update

02.06.2026 - 01:05:34 | boerse-global.de

British American Tobacco faces a guidance test on June 2 as stock slides 6% despite analyst upside. Focus on 2026 targets and smokeless product momentum amid Iran and duty-free headwinds.

BAT's Balancing Act: Smokeless Growth vs. Structural Headwinds in the Half-Year Update - Bild: ĂĽber boerse-global.de
BAT's Balancing Act: Smokeless Growth vs. Structural Headwinds in the Half-Year Update - Bild: ĂĽber boerse-global.de

British American Tobacco finds itself caught between two competing narratives as it prepares to release its half-year trading update on Tuesday. Analysts see a quarter of upside potential from current levels, yet the stock has shed nearly 6% in the past week alone — a divergence that puts the company’s full-year guidance squarely in the crosshairs.

The pre-close update, due at 7:00 BST on 2 June, will be followed by an investor call at 8:30 BST featuring CEO Tadeu Marroco, interim CFO Javed Iqbal, and head of investor relations Victoria Buxton. The market’s attention will zero in on whether management can credibly reaffirm its 2026 targets: currency-adjusted revenue growth of 3% to 5% and a 4% to 6% rise in adjusted operating profit. Those ranges were already pegged at the lower end of BAT’s medium-term ambitions at the start of the year, and the landscape has since grown more challenging.

The stock currently trades at around €53.20, still sporting a year-to-date gain of roughly 10.5% but well off its 52-week high of €57.18. The recent sell-off reflects a familiar pattern: analyst desks remain constructive — UBS recently reiterated a buy with a price target near €67, implying a 25% premium — while short-term traders fret over headwinds that have accumulated since the first quarter. The Iran conflict, pressure on duty-free sales, and shrinking combustible volumes are all weighing on sentiment.

Derren Nathan, equity analyst at Hargreaves Lansdown, noted that BAT entered 2026 at the softer end of its medium-term targets. “Additional stresses have emerged since then,” he said, “particularly the Iran situation, which is affecting both duty-free revenue and cigarette volumes. Investors want to know whether the full-year targets still hold.”

Should investors sell immediately? Or is it worth buying British American Tobacco?

BAT’s defence rests on its smokeless product portfolio. In the first quarter, revenue from non-combustible products climbed 17% on a currency-adjusted basis, with Vuse volumes up 12% and Velo surging 28%. The company aims to reach 50 million adult consumers of smokeless brands such as Vuse, glo, and Velo by 2030, and to have these products account for half of group revenue by 2035. Currently, around 31 million users have adopted them. The half-year update will show whether that momentum is accelerating fast enough to offset the structural erosion in traditional cigarettes, which shrink by roughly 2% annually.

Shareholder returns remain a key backstop. BAT has a ÂŁ1.3 billion share buyback programme running through the end of June, and the dividend yield stands above 5%. These measures are designed to support total shareholder return during the transition, but they have not immunised the stock against recent jitters.

Less visible in the near-term calculus is BAT’s ongoing digital overhaul. The company is establishing a new technology hub in Bengaluru that will centralise cybersecurity, data analytics, artificial intelligence, and digital platforms. While that initiative has little bearing on Tuesday’s numbers, it underscores the broader strategic shift underway.

British American Tobacco at a turning point? This analysis reveals what investors need to know now.

Tuesday’s outcome will hinge on how clearly management defends the existing guidance. A straightforward reaffirmation without caveats would strengthen the recovery narrative; cautious language around duty-free or cigarette volumes would confirm the market’s unease. Either way, the update offers the clearest signal yet on whether the bull case — built on pricing power, smokeless growth, and heavy capital returns — can survive a fresh wave of macro and industry friction.

Ad

British American Tobacco Stock: New Analysis - 2 June

Fresh British American Tobacco information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated British American Tobacco analysis...

So schätzen die Börsenprofis BATs Aktien ein!

<b>So schätzen die Börsenprofis  BATs Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
en | GB0002875804 | BATS | boerse | 69467350 |